Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria.

23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global 23-Valent Pneumococcal Polysaccharide Vaccine market is projected to reach US$ 7051.3 million by 2028 from an estimated US$ 3145.7 million in 2022, at a CAGR of 14.4% during 2023 and 2028.

The major players in global 23-Valent Pneumococcal Polysaccharide Vaccine market include MSD, Sanofipasteur, etc. The top 2 players occupy about 80% shares of the global market. North America and Europe are main markets, they occupy about 50% of the global market. Single Dose Vial is the main type, with a share about 60%. For Children (2-10) is the main application, which holds a share about 40%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for 23-Valent Pneumococcal Polysaccharide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding 23-Valent Pneumococcal Polysaccharide Vaccine.

The 23-Valent Pneumococcal Polysaccharide Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global 23-Valent Pneumococcal Polysaccharide Vaccine market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the 23-Valent Pneumococcal Polysaccharide Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

MSD

Sanofipasteur

CDIBP

Product Type Insights

Global markets are presented by 23-Valent Pneumococcal Polysaccharide Vaccine type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the 23-Valent Pneumococcal Polysaccharide Vaccine are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Single Dose Vial

Pre-filled Syringe

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the 23-Valent Pneumococcal Polysaccharide Vaccine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the 23-Valent Pneumococcal Polysaccharide Vaccine market.

For Children (2-10)

For Person (10-64)

For The Old (Above or equal to 65)

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia-Pacific

China

Japan

South Korea

India

Southeast Asia

Australia

Rest of Asia-Pacific

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the 23-Valent Pneumococcal Polysaccharide Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 23-Valent Pneumococcal Polysaccharide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of 23-Valent Pneumococcal Polysaccharide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the 23-Valent Pneumococcal Polysaccharide Vaccine industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 23-Valent Pneumococcal Polysaccharide Vaccine

1.1 23-Valent Pneumococcal Polysaccharide Vaccine Product Introduction

1.2 Market by Type

1.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Type (2017 VS 2021 VS 2028)

1.2.2 Single Dose Vial

1.2.3 Pre-filled Syringe

1.3 Market by Application

1.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Application (2017 VS 2021 VS 2028)

1.3.2 For Children (2-10)

1.3.3 For Person (10-64)

1.3.4 For The Old (Above or equal to 65)

1.4 Study Objectives

1.5 Years Considered

2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Estimates and Forecasts

2.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2017-2028

2.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2017-2028

2.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region: 2022 Versus 2028

2.3 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2017-2028)

2.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region: 2017-2022

2.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2023-2028)

2.3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2028)

2.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Estimates and Projections by Region (2023-2028)

2.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2017-2022

2.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2023-2028)

2.4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2017-2028)

3.1 Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers by Sales

3.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturer (2017-2022)

3.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturer (2017-2022)

3.2 Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers by Revenue

3.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturer (2017-2022)

3.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturer (2017-2022)

3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Manufacturer (2017-2022)

3.4 Competitive Landscape

3.4.1 Key 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Covered: Ranking by Revenue

3.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Concentration Ratio (CR5 and HHI) & (2017-2022)

3.4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.5 Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution, Product Type

3.5.1 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Manufacturing Base Distribution, Headquarters

3.5.2 Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Type

3.5.3 Date of International Manufacturers Enter into 23-Valent Pneumococcal Polysaccharide Vaccine Market

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.1 MSD

4.1.1 MSD Corporation Information

4.1.2 MSD Description, Business Overview

4.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered

4.1.4 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)

4.1.5 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Product in 2021

4.1.6 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application in 2021

4.1.7 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Geographic Area in 2021

4.1.8 MSD Recent Developments

4.2 Sanofipasteur

4.2.1 Sanofipasteur Corporation Information

4.2.2 Sanofipasteur Description, Business Overview

4.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered

4.2.4 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)

4.2.5 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Product in 2021

4.2.6 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application in 2021

4.2.7 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Geographic Area in 2021

4.2.8 Sanofipasteur Recent Developments

4.3 CDIBP

4.3.1 CDIBP Corporation Information

4.3.2 CDIBP Description, Business Overview

4.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered

4.3.4 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)

4.3.5 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Product in 2021

4.3.6 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application in 2021

4.3.7 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Geographic Area in 2021

4.3.8 CDIBP Recent Developments

5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2028)

5.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022)

5.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2023-2028)

5.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2028)

5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2017-2028)

5.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2022)

5.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2023-2028)

5.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2028)

5.3 23-Valent Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) by Type (2017-2028)

6.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2028)

6.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022)

6.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2023-2028)

6.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)

6.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2017-2028)

6.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2022)

6.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2023-2028)

6.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2017-2028)

6.3 23-Valent Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) by Application (2017-2028)

7.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2017-2028

7.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country

7.2.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2028)

7.2.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2028)

7.3 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type

7.4 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application

8.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2017-2028

8.2 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Region

8.2.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2017-2028)

8.2.2 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2017-2028)

8.3 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type

8.4 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application

9.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2017-2028

9.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country

9.2.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2028)

9.2.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2028)

9.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type

9.4 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application

10.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2017-2028

10.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country

10.2.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2028)

10.2.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2028)

10.3 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type

10.4 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application

11.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2017-2028

11.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country

11.2.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2028)

11.2.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2028)

11.3 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type

11.4 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application

12.1 23-Valent Pneumococcal Polysaccharide Vaccine Supply Chain Analysis

12.2 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials and Upstream Suppliers

12.3 23-Valent Pneumococcal Polysaccharide Vaccine Clients Analysis

12.4 23-Valent Pneumococcal Polysaccharide Vaccine Sales Channel and Sales Model Analysis

12.4.1 23-Valent Pneumococcal Polysaccharide Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales

12.4.2 23-Valent Pneumococcal Polysaccharide Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales

12.4.3 23-Valent Pneumococcal Polysaccharide Vaccine Distributors

13.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Trends

13.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers

13.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges

13.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints

13.5 Porter’s Five Forces Analysis

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

List of Tables

    Table 1. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028

    Table 2. Major Manufacturers of Single Dose Vial

    Table 3. Major Manufacturers of Pre-filled Syringe

    Table 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028

    Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region (US$ Million): 2021 VS 2022 VS 2028

    Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2017-2022) & (K Units)

    Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2023-2028) & (K Units)

    Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2017-2022) & (US$ Million)

    Table 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)

    Table 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturer (2017-2022) & (K Units)

    Table 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturer (2017-2022)

    Table 12. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturer (2017-2022) & (US$ Million)

    Table 13. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturer (2017-2022)

    Table 14. Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Price (2017-2022) & (USD/Unit)

    Table 15. Ranking of Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers by Revenue (US$ Million) in 2021

    Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)

    Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in 23-Valent Pneumococcal Polysaccharide Vaccine as of 2021)

    Table 18. 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Manufacturing Base Distribution and Headquarters

    Table 19. Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Type

    Table 20. Date of International Manufacturers Enter into 23-Valent Pneumococcal Polysaccharide Vaccine Market

    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 22. MSD Corporation Information

    Table 23. MSD Description and Business Overview

    Table 24. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 25. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product

    Table 26. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales Proportion of 23-Valent Pneumococcal Polysaccharide Vaccine by Product in 2021

    Table 27. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales Proportion of 23-Valent Pneumococcal Polysaccharide Vaccine by Application in 2021

    Table 28. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales Proportion of 23-Valent Pneumococcal Polysaccharide Vaccine by Geographic Area in 2021

    Table 29. MSD Recent Development

    Table 30. Sanofipasteur Corporation Information

    Table 31. Sanofipasteur Description and Business Overview

    Table 32. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 33. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product

    Table 34. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales Proportion of 23-Valent Pneumococcal Polysaccharide Vaccine by Product in 2021

    Table 35. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales Proportion of 23-Valent Pneumococcal Polysaccharide Vaccine by Application in 2021

    Table 36. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales Proportion of 23-Valent Pneumococcal Polysaccharide Vaccine by Geographic Area in 2021

    Table 37. Sanofipasteur Recent Development

    Table 38. CDIBP Corporation Information

    Table 39. CDIBP Description and Business Overview

    Table 40. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 41. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product

    Table 42. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales Proportion of 23-Valent Pneumococcal Polysaccharide Vaccine by Product in 2021

    Table 43. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales Proportion of 23-Valent Pneumococcal Polysaccharide Vaccine by Application in 2021

    Table 44. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales Proportion of 23-Valent Pneumococcal Polysaccharide Vaccine by Geographic Area in 2021

    Table 45. CDIBP Recent Development

    Table 46. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)

    Table 47. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2023-2028) & (K Units)

    Table 48. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2022) & (US$ Million)

    Table 49. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)

    Table 50. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)

    Table 51. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2023-2028) & (K Units)

    Table 52. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2022) & (US$ Million)

    Table 53. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)

    Table 54. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)

    Table 55. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2023-2028) & (K Units)

    Table 56. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)

    Table 57. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2023-2028) & (US$ Million)

    Table 58. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)

    Table 59. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)

    Table 60. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2017-2022) & (K Units)

    Table 61. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2023-2028) & (K Units)

    Table 62. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2017-2028) & (US$ Million)

    Table 63. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2023-2028) & (US$ Million)

    Table 64. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)

    Table 65. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)

    Table 66. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)

    Table 67. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2023-2028) & (K Units)

    Table 68. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)

    Table 69. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2023-2028) & (US$ Million)

    Table 70. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)

    Table 71. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)

    Table 72. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)

    Table 73. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2023-2028) & (K Units)

    Table 74. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)

    Table 75. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2023-2028) & (US$ Million)

    Table 76. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)

    Table 77. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)

    Table 78. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)

    Table 79. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2023-2028) & (K Units)

    Table 80. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)

    Table 81. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2023-2028) & (US$ Million)

    Table 82. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)

    Table 83. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)

    Table 84. 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials, Industry Status and Trend

    Table 85. 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials and Upstream Suppliers

    Table 86. 23-Valent Pneumococcal Polysaccharide Vaccine Clients Status and Trend

    Table 87. 23-Valent Pneumococcal Polysaccharide Vaccine Typical Clients

    Table 88. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors

    Table 89. 23-Valent Pneumococcal Polysaccharide Vaccine Market Trends

    Table 90. 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers

    Table 91. 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges

    Table 92. 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints

    Table 93. Research Programs/Design for This Report

    Table 94. Key Data Information from Secondary Sources

    Table 95. Key Data Information from Primary Sources

List of Figures

    Figure 1. 23-Valent Pneumococcal Polysaccharide Vaccine Product Picture

    Figure 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2021 & 2028

    Figure 3. Single Dose Vial Product Picture

    Figure 4. Pre-filled Syringe Product Picture

    Figure 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2021 & 2028

    Figure 6. For Children (2-10) Examples

    Figure 7. For Person (10-64) Examples

    Figure 8. For The Old (Above or equal to 65) Examples

    Figure 9. 23-Valent Pneumococcal Polysaccharide Vaccine Report Years Considered

    Figure 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, (US$ Million), 2017 VS 2021 VS 2028

    Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size 2017-2028 (US$ Million)

    Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2017-2028 (K Units)

    Figure 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Market Share by Region: 2022 Versus 2028

    Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Region (2017-2028)

    Figure 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2017-2028)

    Figure 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturer in 2021

    Figure 17. 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021

    Figure 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2017-2028)

    Figure 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2017-2028)

    Figure 20. 23-Valent Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) by Type (2017-2022) & (USD/Unit)

    Figure 21. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2017-2028)

    Figure 22. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Application (2017-2028)

    Figure 23. 23-Valent Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) by Application (2017-2022) & (USD/Unit)

    Figure 24. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2017-2028 (US$ Million)

    Figure 25. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)

    Figure 26. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)

    Figure 27. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2017-2028 (US$ Million)

    Figure 28. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2028)

    Figure 29. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2017-2028)

    Figure 30. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)

    Figure 31. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)

    Figure 32. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 33. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2028)

    Figure 34. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2028)

    Figure 35. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)

    Figure 36. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)

    Figure 37. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 38. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2028)

    Figure 39. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)

    Figure 40. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)

    Figure 41. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)

    Figure 42. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 43. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2028)

    Figure 44. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2028)

    Figure 45. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)

    Figure 46. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)

    Figure 47. 23-Valent Pneumococcal Polysaccharide Vaccine Supply Chain (Upstream and Downstream Market)

    Figure 48. Global Production Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine Raw Materials by Region in 2021

    Figure 49. 23-Valent Pneumococcal Polysaccharide Vaccine Distribution Channels

    Figure 50. Global 23-Valent Pneumococcal Polysaccharide Vaccine Percentage 2017-2028: Indirect Sales VS Direct Sales

    Figure 51. Global 23-Valent Pneumococcal Polysaccharide Vaccine Percentage 2017-2028: Online Sales VS Offline Sales

    Figure 52. Bottom-up and Top-down Approaches for This Report

    Figure 53. Data Triangulation